BIOMAT Database Logo BIOMAT Database Logo

[Clinical experiments on an antirheumatic drug: 1-ascorbo-alpha-phenylquinoline-gamma-carboxylic acid strontium salt]. 1956

G A MORANDI

UI MeSH Term Description Entries
D011804 Quinolines
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D012216 Rheumatic Diseases Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. Rheumatism,Disease, Rheumatic,Diseases, Rheumatic,Rheumatic Disease
D013324 Strontium An element of the alkaline earth family of metals. It has the atomic symbol Sr, atomic number 38, and atomic weight 87.62.
D017673 Sodium Chloride, Dietary Sodium chloride used in foods. Dietary Sodium Chloride,Table Salt,Chloride, Dietary Sodium,Salt, Table
D018501 Antirheumatic Agents Drugs that are used to treat RHEUMATOID ARTHRITIS. Anti-Rheumatic Agent,Anti-Rheumatic Drug,Antirheumatic Agent,Antirheumatic Disease-Modifying Second-Line Drug,Antirheumatic Drug,DMARD,Disease-Modifying Antirheumatic Drug,Disease-Modifying Antirheumatic Drugs,Anti-Rheumatic Agents,Anti-Rheumatic Agents, Non-Steroidal,Anti-Rheumatic Drugs,Antirheumatic Disease-Modifying Second-Line Drugs,Antirheumatic Drugs,Antirheumatic Drugs, Disease-Modifying,Disease-Modifying, Antirheumatic Second-Line Drugs,Agent, Anti-Rheumatic,Agent, Antirheumatic,Anti Rheumatic Agent,Anti Rheumatic Agents,Anti Rheumatic Agents, Non Steroidal,Anti Rheumatic Drug,Anti Rheumatic Drugs,Antirheumatic Disease Modifying Second Line Drug,Antirheumatic Disease Modifying Second Line Drugs,Antirheumatic Drug, Disease-Modifying,Antirheumatic Drugs, Disease Modifying,Disease Modifying Antirheumatic Drug,Disease Modifying Antirheumatic Drugs,Disease Modifying, Antirheumatic Second Line Drugs,Drug, Anti-Rheumatic,Drug, Antirheumatic,Drug, Disease-Modifying Antirheumatic,Non-Steroidal Anti-Rheumatic Agents

Related Publications

G A MORANDI
[Clinical use of phenylquinoline carboxylic acid].
March 1952, Gazzetta medica italiana,
G A MORANDI
[Results of biological and clinical study of phenylquinoline carboxylic acid].
March 1952, Gazzetta medica italiana,
G A MORANDI
[Clinical experience in rheumatic diseases with 3-hydroxy-2-phenylquinoline-4-carboxylic acid].
January 1953, Reumatismo,
G A MORANDI
[Observations on the action of 2-phenylquinoline-4-carboxylic acid (atophan) on renal function].
January 1952, Archivio di scienze biologiche,
G A MORANDI
[The action of ascorbo-alpha-phenylquinoleine-nu-carboxylate of strontium in the therapy of rheumatism].
January 1955, Concours medical,
G A MORANDI
Studies on derivatives of phenyltetrahydrofuranon-carboxylic acids. I. Derivatives of gamma-phenyltetrahydrofuranon-2-beta-carboxylic acid and gamma-hydroxy-gamma-phenylpropane-alpha, beta-dicarboxylic acid.
January 1968, Archivum immunologiae et therapiae experimentalis,
G A MORANDI
[Enterogastrone and urogastrone in experimental gastric ulcers caused by phenylquinoline carboxylic acid].
February 1953, Giornale italiano di chirurgia,
G A MORANDI
[Action of 3 hydroxyphenylquinoline carboxylic acid and phenylquinoline carboxylic acid on acute pulmonary edema from adrenalin and egg white edema in rats].
April 1952, Bollettino della Societa italiana di biologia sperimentale,
G A MORANDI
Alpha-cycloPNA: 1-aminocylopentane-1-carboxylic acid-derived peptide nucleic acid.
January 2003, Nucleosides, nucleotides & nucleic acids,
G A MORANDI
Discovery of 2-Phenylquinoline-4-Carboxylic Acid Derivatives as Novel Histone Deacetylase Inhibitors.
January 2022, Frontiers in chemistry,
Copied contents to your clipboard!